Sentence examples for burden and the development from inspiring English sources

In early phase pneumonia, protective ventilation with lower tidal volume and higher end expiratory pressure has the potential to reduce the pulmonary bacterial burden and the development of lung injury.

Despite this burden and the development of improved microbiological molecular methods, only few recent studies with well characterized ALRI, clinical diagnoses in which bacterial and viral testing have been additionally performed have been published [ 4- 7].

In the majority of countries, there is a gap between policy makers' recognition of a national chronic disease burden and the development and implementation of chronic disease policies and plans.

Authors of epidemiology textbooks should afford more attention to the neglected areas of measuring disease burden and the development of morbidity metrics and tools for the prioritisation of population health problems.

14 Both the development of an initial response that eradicates the primary tumor burden and the development of an antigen-specific memory response are important for long-term survival.

In Asia, large-scale epidemiological studies are required to update information about the prevalence of CRS, and such studies would provide information for the assessment of the disease burden and the development and promotion of public health policies associated with CRS.

Our study provides important information for the assessment of the economic burden of CRS and the development and promotion of public health policies associated with CRS particularly in developing countries.

These findings might facilitate people's understanding of the epidemiology of CRS and provide important information for the assessment of the economic burden of CRS and the development and promotion of public health policies associated with CRS.

From a technical standpoint, this places a heavy burden on the development and application of appropriate and robust sample preparation systems to enable the use of both microscopic and non-microscopic particle size technologies with minimal error.

While the role of amyloid burden in the development and progression of clinical symptoms remains unclear and under active investigation, plaque clearance has been a key target of numerous clinical trials.

The human immunodeficiency virus (HIV) is a driving force behind the global burden of tuberculosis (TB) and the development of drug-resistant tuberculosis (DR-TB).